Comment
. 2004 Jul 17;329(7458):171; author reply 172.
doi: 10.1136/bmj.329.7458.171-b.
Ginkgo biloba and acetazolamide for acute mountain sickness: exclusion of high risk, low status groups perpetuates discrimination and inequalities
- PMID: 15258082
- PMCID: PMC478272
- DOI: 10.1136/bmj.329.7458.171-b
Item in Clipboard
Comment
Ginkgo biloba and acetazolamide for acute mountain sickness: exclusion of high risk, low status groups perpetuates discrimination and inequalities
BMJ.
.
No abstract available
Comment on
-
Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).BMJ. 2004 Apr 3;328(7443):797. doi: 10.1136/bmj.38043.501690.7C. Epub 2004 Mar 11. BMJ. 2004. PMID: 15070635 Free PMC article. Clinical Trial.
Similar articles
-
Ginkgo biloba and acetazolamide for acute mountain sickness: bias in participants may underestimate effectiveness of agents.BMJ. 2004 Jul 17;329(7458):172; author reply 172. doi: 10.1136/bmj.329.7458.172. BMJ. 2004. PMID: 15258084 Free PMC article. No abstract available.
-
Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.Arch Intern Med. 2005 Feb 14;165(3):296-301. doi: 10.1001/archinte.165.3.296. Arch Intern Med. 2005. PMID: 15710792 Clinical Trial.
-
Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).BMJ. 2004 Apr 3;328(7443):797. doi: 10.1136/bmj.38043.501690.7C. Epub 2004 Mar 11. BMJ. 2004. PMID: 15070635 Free PMC article. Clinical Trial.
-
Ginkgo biloba extract for prevention of acute mountain sickness: a systematic review and meta-analysis of randomised controlled trials.BMJ Open. 2018 Aug 17;8(8):e022005. doi: 10.1136/bmjopen-2018-022005. BMJ Open. 2018. PMID: 30121603 Free PMC article.
-
Ginkgo biloba for prevention of acute mountain sickness: does it work?High Alt Med Biol. 2009 Spring;10(1):33-43. doi: 10.1089/ham.2008.1085. High Alt Med Biol. 2009. PMID: 19278351 Review.
Cited by
-
Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.Cochrane Database Syst Rev. 2017 Jun 27;6(6):CD009761. doi: 10.1002/14651858.CD009761.pub2. Cochrane Database Syst Rev. 2017. PMID: 28653390 Free PMC article.
-
Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.Cochrane Database Syst Rev. 2019 Apr 23;4(4):CD013315. doi: 10.1002/14651858.CD013315. Cochrane Database Syst Rev. 2019. PMID: 31012483 Free PMC article.
-
Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.Cochrane Database Syst Rev. 2018 Mar 12;3(3):CD012983. doi: 10.1002/14651858.CD012983. Cochrane Database Syst Rev. 2018. PMID: 29529715 Free PMC article.
-
Interventions for treating acute high altitude illness.Cochrane Database Syst Rev. 2018 Jun 30;6(6):CD009567. doi: 10.1002/14651858.CD009567.pub2. Cochrane Database Syst Rev. 2018. PMID: 29959871 Free PMC article.
References
-
- Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT) BMJ 2004;328: 797-801. (3 April.) - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
